<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-14T08:36:22Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:2072/458680" metadataPrefix="oai_dc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:2072/458680</identifier><datestamp>2026-03-13T07:56:57Z</datestamp><setSpec>com_2072_98</setSpec><setSpec>col_2072_378192</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>A Longitudinal Analysis Reveals Early Activation and Late Alterations in B Cells During Primary HIV Infection in Mozambican Adults</dc:title>
   <dc:creator>Jiménez, Montse</dc:creator>
   <dc:creator>Pastor Palomo, Lucía</dc:creator>
   <dc:creator>Urrea, Víctor</dc:creator>
   <dc:creator>Rodríguez de la Concepción, María Luisa</dc:creator>
   <dc:creator>Parker, Erica</dc:creator>
   <dc:creator>Fuente-Soro, Laura</dc:creator>
   <dc:creator>Jairoce, Chenjerai</dc:creator>
   <dc:creator>Mandomando, Inacio</dc:creator>
   <dc:creator>Carrillo, Jorge</dc:creator>
   <dc:creator>Naniche, Denise</dc:creator>
   <dc:creator>Blanco, Julià</dc:creator>
   <dc:creator>Universitat Autònoma de Barcelona</dc:creator>
   <dc:subject>B-cell activation</dc:subject>
   <dc:subject>Plasmablasts</dc:subject>
   <dc:subject>Marginal zone (MZ) B cell</dc:subject>
   <dc:subject>Transitional B cell</dc:subject>
   <dc:subject>PD-1</dc:subject>
   <dc:description>Altres ajuts: Melinda Gates Foundation (OPP1068252)</dc:description>
   <dc:description>Primary HIV infection (PHI) and subsequent chronic infection alter B-cell compartment. However, longitudinal analysis defining the dynamics of B-cell alterations are still limited. We longitudinally studied B-cell subsets in individuals followed for 1 year after PHI (n = 40). Treated and untreated chronic HIV infected (n = 56) and HIV-uninfected individuals (n = 58) were recruited as reference groups at the Manhiça District in Mozambique. B cells were analyzed by multicolor flow-cytometry. Anti-HIV humoral response and plasma cytokines were assessed by ELISA or Luminex-based technology. A generalized activation of B cells induced by HIV occurs early after infection and is characterized by increases in Activated and Tissue-like memory cells, decreases in IgM-IgD- (switched) and IgM-only B cells. These alterations remain mostly stable until chronic infection and are reverted in part by ART. In contrast, other parameters followed particular dynamics: PD-1 expression in memory cells decreases progressively during the first year of infection, Transitional B cells expand at month 3-4 after infection, and Marginal zone-like B cells show a late depletion. Plasmablasts expand 2 months after infection linked to plasma viral load and anti-p24 IgG3 responses. Most of well-defined changes induced by HIV in B-cell activation and memory subsets are readily observed after PHI, lasting until ART initiation. However, subsequent changes occur after sustained viral infection. These data indicate that HIV infection impacts B cells in several waves over time, and highlight that early treatment would result in beneficial effects on the B-cell compartment.</dc:description>
   <dc:date>2021</dc:date>
   <dc:type>Article</dc:type>
   <dc:identifier>https://ddd.uab.cat/record/252341</dc:identifier>
   <dc:identifier>urn:10.3389/fimmu.2020.614319</dc:identifier>
   <dc:identifier>urn:oai:ddd.uab.cat:252341</dc:identifier>
   <dc:identifier>urn:articleid:16643224v11</dc:identifier>
   <dc:identifier>urn:pmcid:PMC7844141</dc:identifier>
   <dc:identifier>urn:pmc-uid:7844141</dc:identifier>
   <dc:identifier>urn:pmid:33519823</dc:identifier>
   <dc:identifier>urn:oai:pubmedcentral.nih.gov:7844141</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>Ministerio de Ciencia e Innovación 2011-27901</dc:relation>
   <dc:relation>Ministerio de Economía y Competitividad DTS15/00185</dc:relation>
   <dc:relation>Ministerio de Economía y Competitividad FI12/00096</dc:relation>
   <dc:relation>Frontiers in immunology ; Vol. 11 (january 2021)</dc:relation>
   <dc:rights>open access</dc:rights>
   <dc:rights>Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.</dc:rights>
   <dc:rights>https://creativecommons.org/licenses/by/4.0/</dc:rights>
   <dc:format>application/pdf</dc:format>
   <dc:publisher/>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>